MedKoo Cat#: 523119 | Name: DY-268
Featured

Description:

WARNING: This product is for research use only, not for human or veterinary use.

DY-268 is a trisubstituted-pyrazol carboamide based compound that acts as a potent FXR antagonist (IC50 = 7.5 nM). It does not display any FXR agonistic activity and cytotoxicity.

Chemical Structure

DY-268
DY-268
CAS#1609564-75-1

Theoretical Analysis

MedKoo Cat#: 523119

Name: DY-268

CAS#: 1609564-75-1

Chemical Formula: C30H32N4O5S

Exact Mass: 560.2093

Molecular Weight: 560.67

Elemental Analysis: C, 64.27; H, 5.75; N, 9.99; O, 14.27; S, 5.72

Price and Availability

Size Price Availability Quantity
10mg USD 350.00 2 Weeks
25mg USD 650.00 2 Weeks
50mg USD 950.00 2 Weeks
Bulk Inquiry
Buy Now
Add to Cart
Related CAS #
No Data
Synonym
DY-268; DY 268; DY268;
IUPAC/Chemical Name
1-[(3-Methoxyphenyl)methyl]-N-[4-methyl-3-(4-morpholinylsulfonyl)phenyl]-3-(4-methylphenyl)-1H-pyrazole-4-carboxamide
InChi Key
KQSPAAPFKIEUGH-UHFFFAOYSA-N
InChi Code
InChI=1S/C30H32N4O5S/c1-21-7-10-24(11-8-21)29-27(20-33(32-29)19-23-5-4-6-26(17-23)38-3)30(35)31-25-12-9-22(2)28(18-25)40(36,37)34-13-15-39-16-14-34/h4-12,17-18,20H,13-16,19H2,1-3H3,(H,31,35)
SMILES Code
O=C(C1=CN(CC2=CC=CC(OC)=C2)N=C1C3=CC=C(C)C=C3)NC4=CC=C(C)C(S(=O)(N5CCOCC5)=O)=C4
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO, not in water
Shelf Life
>2 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info
Product Data
Biological target:
DY268 is a farnesoid X receptor (FXR) antagonist (IC50=7.5 nM in a time-resolved FRET assay).
In vitro activity:
TBD
In vivo activity:
TBD
Solvent mg/mL mM
Solubility
DMSO 78.0 139.18
Note: There can be variations in solubility for the same chemical from different vendors or different batches from the same vendor. The following factors can affect the solubility of the same chemical: solvent used for crystallization, residual solvent content, polymorphism, salt versus free form, degree of hydration, solvent temperature. Please use the solubility data as a reference only. Warming and sonication will facilitate dissolving. Still have questions? Please contact our Technical Support scientists.

Preparing Stock Solutions

The following data is based on the product molecular weight 560.67 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
Formulation protocol:
TBD
In vitro protocol:
TBD
In vivo protocol:
TBD
1: Roman-Lopez J, Correcher V, Garcia-Guinea J, Prado-Herrero P, Rivera T, Lozano IB. Effect of the chemical impurities on the luminescence emission of natural apatites. Spectrochim Acta A Mol Biomol Spectrosc. 2014 May 21;126:142-7. doi: 10.1016/j.saa.2014.01.128. Epub 2014 Feb 7. PubMed PMID: 24594886. 2: Zhang Y, Popov AA, Schiemenz S, Dunsch L. Synthesis, isolation, and spectroscopic characterization of holmium-based mixed-metal nitride clusterfullerenes: HoxSc3-xN@C80 (x=1, 2). Chemistry. 2012 Jul 27;18(31):9691-8. doi: 10.1002/chem.201200574. Epub 2012 Jun 28. PubMed PMID: 22745152. 3: Evans WJ, Lee DS, Ziller JW. Reduction of dinitrogen to planar bimetallic M2(mu-eta 2:eta 2-N2) complexes of Y, Ho, Tm, and Lu using the K/Ln[N(SiMe3)2]3 reduction system. J Am Chem Soc. 2004 Jan 21;126(2):454-5. PubMed PMID: 14719928. 4: Hosoya Y. Five-year color changes of light-cured resin composites: influence of light-curing times. Dent Mater. 1999 Jul;15(4):268-74. PubMed PMID: 10551095. 5: Dupas B, Bach-Gansmo T, Meflah K, Muller RN. Synergistic effects of relaxation and susceptibility in differentiation between compartmentalized and noncompartmentalized tissues. Invest Radiol. 1998 May;33(5):268-72. PubMed PMID: 9609485. 6: Sebastiani G, Godtliebsen F, Jones RA, Haraldseth O, Muller TB, Rinck PA. Analysis of dynamic magnetic resonance images. IEEE Trans Med Imaging. 1996;15(3):268-77. PubMed PMID: 18215908. 7: Gruwel ML, Alves C, Schrader J. Na(+)-K(+)-ATPase in endothelial cell energetics: 23Na nuclear magnetic resonance and calorimetry study. Am J Physiol. 1995 Jan;268(1 Pt 2):H351-8. PubMed PMID: 7840283. 8: Weisel JW, Francis CW, Nagaswami C, Marder VJ. Determination of the topology of factor XIIIa-induced fibrin gamma-chain cross-links by electron microscopy of ligated fragments. J Biol Chem. 1993 Dec 15;268(35):26618-24. PubMed PMID: 7902838.